Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Neoplasm
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Clonality=== Neoplastic tumors are often [[Tumour heterogeneity|heterogeneous]] and contain more than one type of cell, but their initiation and continued growth are usually dependent on a single population of neoplastic cells. These cells are presumed to be [[Monoclonality|monoclonal]] β that is, they are derived from the same cell,<ref>{{Cite web|url=http://www.medterms.com/script/main/art.asp?articlekey=2754|title=Medical Definition of Clone|access-date=2015-02-10|archive-date=2012-10-25|archive-url=https://web.archive.org/web/20121025074001/http://www.medterms.com/script/main/art.asp?articlekey=2754|url-status=dead}}</ref> and all carry the same [[mutation|genetic]] or [[epigenetics|epigenetic]] anomaly β evident of clonality. For lymphoid neoplasms, e.g. [[lymphoma]] and [[leukemia]], clonality is proven by the amplification of a single rearrangement of their [[immunoglobulin]] gene (for [[B cell]] lesions) or [[T cell receptor]] gene (for [[T cell]] lesions). The demonstration of clonality is now considered to be necessary to identify a lymphoid cell proliferation as neoplastic.<ref name="pmid7990861">{{cite journal |vauthors=Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS | title = The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation | journal = N. Engl. J. Med. | volume = 332 | issue = 1 | pages = 19β25 |date=January 1995 | pmid = 7990861 | doi = 10.1056/NEJM199501053320104 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)